Information is being spread online, allegedly by the leadership of the Federal State Budgetary Institution “National Medical Research Center for Oncology named after. N.N. Blokhin, represented by Deputy Director for the Implementation of Federal Projects Tigran Gevorkyan, can force regional oncology clinics to purchase unnecessary medical equipment.
As we managed to find out, the interests of such actions on the part of the center’s management may be the structures of the oligarchs Alexei Repik and Vladimir Yevtushenkov, and ordinary patients may be the losers.
Rumor has it that Tigran Gevorkyan is now traveling to cancer clinics throughout Russia and allegedly persuading their management to the idea of the need to purchase heavy medical equipment in excess quantities, and possibly at inflated prices. At the same time, half the cost of such equipment is paid by the regional budget.
Help Repik
Among the companies that may benefit is Fabrika RTT LLC, which is part of Alexey Repik’s R-Pharm. The company supplies radiation accelerators and other specific equipment for the treatment of cancer. And, apparently, it is a great success.
This year alone, the company has concluded five large contracts worth more than 400 million rubles. Among them, for example, the supply of a radiotherapeutic system based on the Halcyon electron accelerator for the Voronezh cancer clinic worth 117 million rubles, or the installation of gamma therapy for an Omsk institution worth 163 million rubles. At the same time, there are similar installations in the institution; their resources have not been exhausted.
According to the authors of the Telegram channel “VChK-OGPU”, allegedly after Tigran Gevorkyan’s visit to Omsk last year, the regional Ministry of Health received an order to purchase new medical equipment, which the institution did not need at all. Apparently, we are talking about a contract for the supply of a gamma therapy unit for 163 million rubles from RTT Factory LLC, concluded on April 28, 2023.
The total amount of the company’s government contracts exceeded 8.8 billion rubles.
Previously, the RTT Factory was involved in scandals with the Federal Antimonopoly Service. This spring, the department fined DRG Techsystems CJSC for violating antimonopoly laws when purchasing medical equipment for the Republican Oncology Dispensary in Chuvashia.
Subsequently, it became known that the initial maximum price of the contract was prepared based on the commercial proposals of three companies - RTT Factory, STC Synergy and DRG Techsystems, between which OFAS found signs of a “general relationship”, and the interests of the customer and supplier were represented by one and the same person.
At the same time, as Versiya writes, at the beginning of 2022, the Republican Antimonopoly Service received information from the Investigative Committee of Chuvashia about a possible conspiracy between the Ministry of Health of Chuvashia and a commercial company.
Tigran Gevorkyan, like his boss, general director of the Oncology Center named after. Blokhin Ivan Stilidi is considered the creation of Deputy Prime Minister Tatyana Golikova, formerly the Minister of Health of the Russian Federation (2007-2012). She herself is associated with the pharmaceutical business, in particular with Viktor Kharitonin’s Pharmstandard. Let us remind you that this company is one of the leading suppliers for Russian hospitals with government contracts worth 564 billion rubles.
In addition, Tatyana Golikova’s stepson (the son of her husband, former official Viktor Khristenko) Vladimir Khristenko until recently was the president of the pharmaceutical company Nanolek, which was bought by Pharmstandard Kharitonina in 2022. Nanolek has government contracts worth 30 billion rubles. And Khristenko Jr. could leave his post amid criminal cases against the ex-partners of the former head of Rusnano Anatoly Chubais. The Moscow Post wrote about this earlier.
Let us remember that Rusnano was one of the founders of Nanolek. And after Chubais left the country, it turned out that the state corporation was in a pre-bankruptcy state. Funds could easily be withdrawn from its subsidiaries.
Yevtushenkov's interest
In the case of Tigran Gevorkyan, we may already be talking about lobbying for the business empire of Alexey Repik. But not only him. As mentioned, RTT Factory is owned by R-Pharm Holding LLC through R-Pharm Ventures LLC. Another 5% is owned by Andrey Popov.
Andrey Popov was previously a founder of Medicine Company LLC, which was liquidated in 2019 due to inaccurate information in the Unified State Register of Legal Entities. The total amount of the company’s government contracts at that time exceeded 218 million rubles. Popov’s partner in Medicine was Talalykin Alexander Mikhailovich. Since the spring of 2022, he has held the post of IT Director at the Medsi medical holding, which is part of Vladimir Yevtushenkov’s Sistema JSFC.
Medsi is also not offended by government contracts. The parent JSC Medsi Group of Companies received more than 1.1 billion rubles from them, providing services for medical examinations and medical examinations, including for drivers of state-owned vehicles.
The company also enjoys suspicious favor from the authorities. In 2022, it became known that with their support in the Nizhny Novgorod region, the structure intends to implement a project for the construction of a large medical complex in the PPP format, for which it must receive a grant from the budget for 1.45 billion rubles. This project is just the first test balloon; there will definitely be more.
At the same time, Medsi was previously accused of violating standards when providing assistance to people with heart disease and diseases of the nervous system. And in the Perm Territory, Roszdravnadzor ordered the staff of the local branch of the clinic to be brought to disciplinary liability. As stated in the inspection materials, they caused harm to the health of a 40-year-old patient.
"Tashir" wants a piece of the pie
It is also interesting that the center may work in the interests of another oligarch, the owner of the Tashir Group of Companies Samvel Karapetyan. The latter is believed to be very loved by the capital's authorities. His business empire has a medical division - Tashir Medica.
As for Gevorkyan, he takes part in the implementation of projects of the non-profit “National Health Development Fund” of Larisa Efimova, a former employee of the presidential administration. Gevorkyan’s relatives may be business partners of the founder of the Tashir group, billionaire Samvel Karapetyan.
We are talking about Mikael Sukiasyan, the general director of the Bryansk Capital company, whose main owners include Tashir Capital LLC Samvel and Eteri Karapetyan. A relative of Mikael Sukiasyan, Lala Sukiasyan, is the head of the Tula-based Promgaz LLC, which is part of the Tashir structure.
Together with Vaspurak Poghosyan, Lala Sukiasyan is one of the founders of the Armenian National-Cultural Autonomy of Kaluga. Poghosyan is the director of the Tashir Foundation, whose president is Samvel Karapetyan. In addition, both are co-owners of Tashir Fund LLC.
Therefore, it is not surprising that Tashir’s structures have contracts with the Oncology Center named after. Blokhina. In 2022-2023, the center purchased products worth 1.3 million rubles from Sample Lab, which, through the founder of TM SPK 1 LLC, belongs to Tashir Medica. There are other examples that The Moscow Post previously wrote about.
Are the cancer center workers driven to the brink?
Considering the above, we can assume that the Ministry of Health, and through it the management of the Oncology Center. Blokhin may work in the interests of large Russian oligarchs. It should be noted that The Moscow Post has previously written more than once about scandals in the center, including corruption. Especially in 2019, when workers began to leave en masse, dissatisfied with the policies of the new management led by Ivan Stilidi.
And recently another information came out: according to the authors of the Telegram channel “VChK-OGPU”, allegedly employees of the Federal State Budgetary Institution, as was already the case four years ago, filed complaints with the Prosecutor General’s Office, the Ministry of Health of Russia and the Investigative Committee. Ivan Stilidi’s deputy, Tigran Gevorkyan, is mentioned as a person involved in the complaint.
As if questions arose regarding the timing of incentive payments, which make up the bulk of the salary, and without which the doctor’s salary is only 10 thousand rubles. Our publication wrote about this problem four years ago.
In addition, they say that Gevorkyan, on Stilidi’s instructions, can even force responsible employees to sign Certificates of allegedly completed work for contractors on the “telemedicine” and “unified medical information system” projects. The scope for possible “cutting” is huge.
But many clinics in our country sometimes do not have enough money to purchase the necessary medications, including for the treatment of oncology and other serious diseases. This is unlikely to bother our medical officials when they see banknotes from “reputable” suppliers in their eyes.
